Shijiazhuang No. 4 Pharmaceutical Co., Ltd. is Recoganized as Top 50 Enterprises for Chemical Pharmaceutical Products

2018年度中国医药工业百强系列榜单由米内研究院组织中国医药工业百强排行榜专家委员会，依托米内网在中国独家开发运行多年的三大终端六大市场终端格局数据库，针对医药工业企业，从两大最重要的维度（创新驱动力和专业推广力）进行评选。由南方医药经济研究所标点信息集团主办的“中国医药工业百强榜”，素有“中国医药界奥斯卡”之称，是国内最受关注、最具权威的医药排行榜之一。百强企业是中国医药行业的中坚力量，代表着我国医药工业的最高水平。

In 2018, the top 100 list of China's pharmaceutical industry is selected from two most important dimensions (innovation driving force and professional promotion force) by the expert committee of the top 100 list of China's pharmaceutical industry organized by Menet Research Institute, relying on the database of three terminals and six market terminals exclusively developed and operated by Menet in China for many years. The "top 100 list of China's pharmaceutical industry" sponsored by the punctuation information group of Southern Institute of pharmaceutical economics, known as the "Oscar of China's pharmaceutical industry", is one of the most concerned and authoritative pharmaceutical rankings in China. Top 100 enterprises are the backbone of China's pharmaceutical industry, representing the highest level of China's pharmaceutical industry.

作为国内制药企业的优秀代表，公司始终致力于品牌建设,坚持“以质爱民,诚信为本”的经营理念,以“做好药，为人类”为己任,以过硬的产品质量和周到完善的服务，打造出“石四药”优秀的品牌文化。近年来,公司以创新提升品牌价值，年年都有新项目，年年都有新产品投放市场，经济效益保持稳定持续增长。一方面依靠管理创新、技术创新不断提升成本优势；另一方面，通过经营理念创新从供给终端着手，实现经营逆势增长跨出适应新常态到引领新常态关键步。近年来，公司始终坚持创新、质量和品牌同步伐齐发展战略，连续荣登制药百强榜,成为行业的龙头企业。

As an excellent representative of domestic pharmaceutical enterprises, Shijiazhuang No. 4 Pharmaceutical Co., Ltd. has always been committed to brand building, adhere to the business philosophy of "quality, love for the people, integrity-based", take "good medicine, for humanity" as its own responsibility, with excellent product quality and thoughtful and perfect service, to create a "SSY" excellent brand culture. In recent years, the company has improved its brand value by innovation, with new projects every year and new products put on the market every year, with stable and sustained economic growth. On the one hand, it relies on management innovation and technological innovation to continuously improve the cost advantage; on the other hand, it starts from the supply terminal through the innovation of business philosophy, so as to realize the sales growth. In the recent years, the company has always adhered to the strategy of simultaneous development of innovation, quality and brand, and has been listed in the top 100 pharmaceutical companies, becoming the leading enterprise in the industry.